Don't worry about Humira biosimilars, the pipeline will deliver, AbbVie says - BioPharma Dive

Don't worry about Humira biosimilars, the pipeline will deliver, AbbVie says  BioPharma Dive

AbbVie on Thursday reported sales of its flagship product Humira fell by more than 5% in the first quarter of 2019 compared with the same period a year ago.